Skip to main content
. 2013 Oct 31;99(1):315–321. doi: 10.1210/jc.2013-3168

Table 2.

Laboratory and Imaging Results of Study Samplea

Variable Men (n = 197) Women (n = 253) All (n = 450) P Value
Sclerostin, pg/mL 1217 ± 447 (1119) 1043 ± 343 (988) 1119 ± 401 (1040) <.0001
Aortoiliac CP mass, mg Ca2+ 1834 ± 3370 (328) 1442 ± 2494 (224) 1613 ± 2910 (282) .0717
Aortoiliac CP mass > 0, % 81.3 73.3 76.8 .0466
Carotid CP mass, mg Ca2+ 61.6 ± 165.5 (1.0) 34.2 ± 98.0 (0.0) 46.2 ± 132.4 (0.0) .0211
Carotid CP mass > 0, % 51.8 43.4 47.1 .079
Coronary CP mass, mg Ca2+ 373.4 ± 678.8 (45.0) 215.4 ± 616.0 (4.0) 284.3 ± 648.2 (13.0) .0005
Coronary CP mass > 0, % 68.2 58.7 62.9 .0398
Serum creatinine, mg/dL 1.1 ± 0.3 (1.0) 0.9 ± 0.3 (0.8) 1.0 ± 0.3 (0.9) <.0001
C-reactive protein, mg/dL 0.7 ± 1.1 (0.3) 1.4 ± 2.3 (0.7) 1.1 ± 1.9 (0.5) <.0001
MCP-1, pg/mL 248.6 ± 107.4 (227.6) 236.6 ± 101.0 (212.7) 243.3 ± 104.7 (218.7) .1867
Urine ACR, mg/g 144.7 ± 490.1 (24.1) 148.3 ± 598.9 (11.1) 146.7 ± 552.9 (15.0) .0166
GFR,(ml/min/1.73 m2 97.0 ± 26.6 (92.6) 93.8 ± 27.7 (93.7) 95.2 ± 27.3 (93.3) .217
Fasting glucose, mg/dL 158.1 ± 68.6 (140.0) 144.4 ± 61.5 (130.0) 150.4 ± 65.0 (134.5) .0299
HbA1c, % 8.2 ± 1.9 (7.9) 8.0 ± 2.0 (7.6) 8.1 ± 2.0 (7.7) .2643
Total cholesterol, mg/dL 173.9 ± 47.5 (169.0) 184.1 ± 44.6 (176.0) 179.7 ± 46.1 (173.0) .007
HDL-cholesterol, mg/dL 44.5 ± 12.1 (43.0) 50.5 ± 14.3 (48.0) 47.8 ± 13.7 (46.0) <.0001
LDL-cholesterol, mg/dL 102.4 ± 35.7 (98) 109.3 ± 37.8 (100) 106.3 ± 37 (100) .576
Triglycerides, mg/dL 139.4 ± 178.6 (105.0) 123.4 ± 104.2 (97.0) 130.4 ± 141.7 (101.0) .336
TvBMD, mg/cm3 202.2 ± 48.7 (199.7) 209.5 ± 55.0 (205.3) 206.3 ± 52.4 (204.8) .203
LvBMD, mg/cm3 179.4 ± 44.5 (179.5) 181.7 ± 48.9 (177.8) 180.7 ± 47.0 (179.0) .6464

Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; MCP-1, monocyte chemotactic protein-1.

a

Unless indicated otherwise, results are shown as mean ± SD (median). P values are derived from the test comparing the distributions between men and women.